Journey Medical (DERM) Other financing activities (2021 - 2023)

Journey Medical has reported Other financing activities for 3 years, with the latest figure at $380000.0 in Q4 2023.

• For the quarter ending Q4 2023, Other financing activities changed N/A year-over-year to $380000.0; the trailing twelve-month figure through Dec 2025 stood at $380000.0 (changed N/A YoY), and the FY2025 full-year result was $75000.0, up 50.0% from the prior year.
• Other financing activities for Q4 2023 stood at $380000.0, up from -$157000.0 in the prior quarter.
• The five-year high for Other financing activities was $1.4 million in Q1 2021, with the low at -$446000.0 in Q4 2021.
• Historically, Other financing activities has averaged $306285.7 across 3 years, with a median of $371000.0 in 2022.
• The largest YoY upside for Other financing activities was 72.58% in 2022 against a maximum downside of 187.71% in 2022.
• Journey Medical's Other financing activities stood at -$446000.0 in 2021, then soared by 64.8% to -$157000.0 in 2022, then surged by 342.04% to $380000.0 in 2023.
• The last three Other financing activities figures came in at $380000.0 (Q4 2023), -$157000.0 (Q2 2022), and $371000.0 (Q1 2022), per Business Quant data.